Organizing Committee
OCM Member
Chancellor’s Professor
Indiana University , USA
Biography :

Rex Stockton is the Class of 1969 Chancellor’s Professor in the Department of Counseling and Educational Psychology at Indiana University where he has held a wide variety of academic, administrative and professional responsibilities. For several years he was Associate Dean in the Office of the Vice President and Dean for Research and Advanced Study. In this capacity, he assisted in the coordination and administration of research and academic programs. Dr. Stockton has directed or participated at a senior level in a series of funded research and development studies. Currently, he leads a project focusing on the social emotional components of having HIV/AIDS. The population he works most is in Sub-Saharan Africa, primarily Botswana. In collaboration with colleagues he has completed several country wide studies in this area. Dr. Stockton has been active in leadership roles in major professional organizations. Also he is the recipient of several research and teaching awards.

Research Interest :

Dr. Stockton has been active in developing training procedures for group counseling. He has published extensively and conducted many workshops, nationally and internationally, in this area. Dr. Stockton is a recipient of the Burton W. Gorman Teaching Award at Indiana University and the Association for Counselor Education and Supervision's Distinguished Mentor Award.

OCM Member
DIRECTOR
University of Oxford , United Kingdom
Biography :

Rafael Perera is a Statistician, Professor of Medical Statistics, and the Head of Statistics in the Nuffield Department of Primary Care Health Sciences, University of Oxford, UK. He is Director of the Monitoring and Diagnosis group, Oxford (MaDOx) and Director of Research Methodologies at the Centre for Evidence Based Medicine (CEBM) in Oxford. He is also a Fellow of St Hugh’s College, Oxford. He said,"My main activity is as Director of the Statistics group in the Nuffield Department of Primary Care Health Sciences (NDPCHS) which I joined in 2002. I am involved in a number of research activities within the department; however my main focus is the study of Monitoring for the management of long-term conditions (e.g. Type 2 diabetes, hypertension, etc). I have overseen the development of one of the strongest methodological/statistical groups in the UK (across all clinical areas) with a particular emphasis on Monitoring, with my group achieving national and international recognition [NIHR Progress Report 2008/09-Delivering Health Research]. As part of this, I am the Statistical director of our fully accredited Clinical Trials Unit (only 55 units have received full accreditation in the UK). I sit on a range of national and international panels and boards that influence healthcare policy at different levels (funding boards, steering groups, data monitoring boards, etc.). I am also a Statistical Editor of the BMJ (since 2011) and was a member of the NIHR Health Technology Assessment (HTA) Commissioning board until 2012, joining in 2007 as Associate Member becoming a full Board Member in 2009. I am also Director of Research Methodologies in the Centre for Evidence Based Medicine (CEBM) as well a fellow at St Hugh’s college Oxford."

Research Interest :

Professor Perera’s primary research program focuses on monitoring in primary care, meta-analysis methods, methodology for studying infectious diseases in children, and assessing complex interventions. In the last five years, his research focus has turned to managing chronic conditions. He is currently PI on an NIHR (UK) funded Programme grant on Monitoring Long term conditions in Primary Care, focusing on improving the evidence for the management of Chronic Kidney Disease and Chronic Heart Failure. He is the author of more than 150 publications focusing on monitoring in primary care, meta-analysis methods, methodology for studying infectious diseases in children, and assessing complex interventions.

OCM Member
DIRECTOR
University of Strasbourg , France
Biography :

Marc H V Van Regenmortel is currently an Emeritus Research Director at the CNRS (French National Research Center) in the School of Biotechnology of the University of Strasbourg, France. He was for 22 years Director of the Immunochemistry Laboratory at the CNRS Molecular Biology Institute in Strasbourg and previously was a professor at several universities in South Africa and France. He served (1984-1990) as Vice Chairman and Chairman of the Virology Division of the International Union of Microbiological Societies (IUMS) and was Secretary General of IUMS from 1990 to 1999. He was also for six years (1996-2002) President of the International Committee on Taxonomy of Viruses. He supervised the research work of 30 PhD students and has published 395 research and review papers as well as 17 books in the fields of Virology and Immunochemistry. In 2009 he co-edited with Brian Mahy of the CDC in Atlanta, the third edition of the Encyclopedia of Virology in 5 volumes published by Elsevier. He is currently Editor-in-Chief of Archives of Virology and Journal of Molecular Recognition, An Executive Editor of Analytical Biochemistry, An Associate Editor of Advances in Virus Research, Frontiers in Immunotherapies and Vaccines, Journal of Immunological Methods, ISRN Immunology, Bionomina and Expert Reviews of Proteomics.

OCM Member
Associate Professor
University of California , USA
Biography :

Sara H. Browne, M.D. is an Associate Professor of Clinical Medicine in the Department of Medicine, Division of Infectious Diseases, at the University of California, San Diego (UCSD). Dr. Browne received her undergraduate education at the University of Cape Town, RSA and her medical degree from the Oxford University School of Medicine. She has a master of public health from the Harvard University School of Public Health, where she was a Fulbright Scholar. She completed her license in the United Kingdom at the John Radcliffe Hospital, Oxford, UK. She did her residency in Internal Medicine at Stanford University Medical Center, where subsequently completed a Clinical Pharmacology Fellowship at Stanford University and an Infectious Diseases Fellowship at UCSD.

Research Interest :

Since joining the UCSD faculty in 2006, Dr. Browne’s main focus has been Global Health and more recently Mobile Health. She has partnered with 3 institutions in South Africa (Stellenbosch University in the Western Cape and Rhodes University, Walter Sisulu University in the Eastern Cape) to support the development of skilled medically trained research faculty locally, to better address clinical research questions crucial to the combat and treatment of the HIV/TB epidemics in Southern Africa. She has successfully mentored South African medical faculty in the design and development of three NIH-funded international HIV research projects in the areas of ART adherence, metabolic side effects in ART and transmitted HIV resistance. Research from these partnerships continues to yield both vital clinical data and clinical tools to implement in the field. Dr. Browne currently conducts translational research and clinical trials to analyze and support patient medication adherence and promote medication literacy in the treatment of HIV/AIDS, TB, and chronic diseases. She seeks to provide new paradigms of healthcare delivery especially in the arena of patient self-management with the use of novel mobile health (mHealth) technologies. In collaboration with Proteus Digital Health, who have developed an ingestible event marker that is able to capture oral ingestion medication, Dr. Browne is investigating the efficacy of mHealth sensor technology to monitor treatment of Mycobacterium tuberculosis. She is an Alliance Healthcare Foundation Innovation Award recipient for this work. Dr. Browne also has a strong background in laboratory-based research, she has performed work on signal transduction in neurobiology and in microbial genomics. She continues to collaborate with the bacterial pathogenesis group led by Dr. Don Guiney and an HIV Malignancy Group led by Dr. Davey Smith.

OCM Member
DIRECTOR
University of California , USA
Biography :

Dr. Busch is the Director of Blood Systems Research Institute, Senior Vice President for Research & Scientific Programs of BloodSystems, and Professor of Laboratory Medicine at the University of California, San Francisco. He earned his Bachelor of Science degree from the UCSB, and his MS, MD and PhD degrees from the UCSC and completed his residency at UCSF. He has played a leadership role in a number of national multi-center research studies funded by NIH and CDC contracts and has directed numerous NIH and CDC grant-funded studies based at BSRI and conducted in collaboration with UCSF, UCB and other national and international institutions. Dr. Busch has published nearly 500 peer-reviewed original scientific articles, and over 150 review articles, editorials and book chapters.

Research Interest :

I direct a large, extramurally-funded research program, a division of the 2nd-largest blood donor collection/distribution program in the US, focused on blood safety and transfusion medicine: detection, natural history and pathogenesis of infectious/non-infectious diseases (e.g., HIV, HBV, HCV, parvo B19, Chagas' disease, dengue) and other complications (transfusion-related acute lung injury, TRALI; microchimerism). My major research interests include the epidemiology, natural history, pathogenesis, and laboratory evaluation of transfusion-associated infections, blood safety implications of new and emerging viruses, and immunological consequences of transfusion. I have focused on a wide spectrum of transfusion-transmitted infectious diseases and immunological complications to enhance blood safety and to capitalize on the unique opportunities for natural history and pathogenesis research derived from identification of research subjects as a result of large-scale blood and plasma donor screening.

OCM Member
Senior Researcher
University of Buenos Aires , Argentina
Biography :

Carolina A. Berini was born in 1978 in Buenos Aires, Argentina. She finished her high school in Duino, Trieste, Italy. After moving back from Italy, she received her B.S (2005) and PhD. degrees (2010) from the University of Buenos Aires under the direction of Dr. Mirna Biglione. She joined the National Reference Center for AIDS in 2002 as an undergraduate student; and after her post-doctoral fellowship at the Institute of Biomedical Research on retroviruses and AIDS, she continued as a researcher. She has always been involved in diagnosis; follow up of HTLV-1/2 patients and molecular epidemiology in populations such us men who have sex with men, sex workers, drug users, pregnant women, blood donors and Amerindians. She has also conducted molecular biology and basic research on HLA and galectines in relation to HTLV-1/2 infection. In 2004 she joined the Department of Microbiology, Parasitology and Immunology, School of Medicine, University of Buenos Aires as a teacher assistant and is still part of the permanent staff.

Research Interest :

Her research interests cover the development of diagnostic kits, epidemiology and molecular biology.

OCM Member
Professor
University of South Florida , USA
Biography :

Richard Dembo is a Professor of Criminology at the University of South Florida in Tampa. He received his Ph.D. in sociology from New York University. He has conducted extensive research on the relationship between drug use and delinquency; has published three books and over 180 articles, book chapters and reports in the fields of criminology, substance use, mental health, and program evaluation; and has guest edited five special issues of journals addressing the problem of drug misuse. He is a member of the editorial boards of The International Journal of the Addictions (renamed Substance Use and Misuse), Violence, Aggression and Terrorism, the Journal of Drug Issues, the Journal of Child and Adolescent Substance Abuse, the Journal of Offender Rehabilitation, and Neurobehavioral HIV Medicine. He has served as a consultant to the National Institute of Justice, the Office of Juvenile Justice and Delinquency Prevention, the National Institute on Drug Abuse, the National Institute of Mental Health, the Center for Substance Abuse Treatment, the Office of Substance Abuse Prevention, and the National Science Foundation; and is a reviewer of manuscripts for numerous professional journals. He is Past-Chair of the American Sociological Association Section on Alcohol and Drugs. He has extensive experience working with troubled youths in a variety of settings and in applying research technology to social problems. He recently completed a NIDA funded experimental, longitudinal service delivery project designed to implement and test a Family Empowerment Intervention involving high risk youth and their families. He is currently involved in: (1) a NIDA funded truancy intervention project, (2) a Research Center as part of the NIDA, National Criminal Justice Drug Abuse Treatment Research Studies (CJDATS-2) Cooperative Agreement initiative, and (3) a NIDA-funded multidisciplinary Research Core Center (P30 grant) focusing on research into co-occurring mental health and substance use disorders within the justice system. He is also involved in the Casey Foundation, Juvenile Detention Alternatives Initiative in Hillsborough County. He helped develop the Hillsborough County Juvenile Assessment Center in Tampa, and supports JAC operations by: (1) completing special research studies, and (2) developing, implementing and evaluating the impact of innovative service delivery projects for youth processed at the JAC and their families. He has been a major party in the flow of millions of dollars in federal, state and local funds into the University of South Florida and the Tampa Bay area for various research and service delivery projects addressing the needs of high risk youth, their families and their surrounding communities.

Research Interest :

He recently completed a NIDA funded experimental, longitudinal service delivery project designed to implement and test a Family Empowerment Intervention involving high risk youth and their families. He is currently involved in: (1) a NIDA funded truancy intervention project, (2) a Research Center as part of the NIDA, National Criminal Justice Drug Abuse Treatment Research Studies (CJDATS-2) Cooperative Agreement initiative, and (3) a NIDA-funded multidisciplinary Research Core Center (P30 grant) focusing on research into co-occurring mental health and substance use disorders within the justice system. He is also involved in the Casey Foundation, Juvenile Detention Alternatives Initiative in Hillsborough County. He helped develop the Hillsborough County Juvenile Assessment Center in Tampa, and supports JAC operations by: (1) completing special research studies, and (2) developing, implementing and evaluating the impact of innovative service delivery projects for youth processed at the JAC and their families. He has been a major party in the flow of millions of dollars in federal, state and local funds into the University of South Florida and the Tampa Bay area for various research and service delivery projects addressing the needs of high risk youth, their families and their surrounding communities.

OCM Member
Principle Investigator
Fudan University , China
Biography :

Dr. Yan Dapeng graduated from the School of life science and technology, Tongji University. Major in biotechnology in 2003-2007, he completed his Ph. D in the Medical School of University of Athens in Greece. He worked as a Research fellow at Laboratory of Diane Mathis and Christophe Benoist (both are members of National Academy of Sciences), department of Microbiology and Immunobiology, Harvard Medical School, Boston, MA. (2013-2015). Currently he is working as a Professor,in Department of Immunology, Fudan University, China.

Research Interest :

1) Many pathogens developed complex and efficient anti-immune strategies to interfere with host immune responses, which can result in diseases or chronic infections. How do these “smart” pathogens evade from the host immune response? Our goal is to clarify the interaction mechanism of pathogen and host proteins during infection process at molecular, cellular and animal levels, which will not only provide new molecular basis for the pathogenic mechanism of pathogen proteins in immune system, but also supply important theoretical evidence for the development of clinical strategies for infection diseases. 2) FoxP3+ T regulatory (Treg) cells help maintain lymphoid homeostasis in many immunological contexts: tolerance to self versus autoimmune deviation, foeto-maternal tolerance, allergy, responses to pathogens, and interactions with commensal microbes. Our group mainly focuses on the role of phosphatases on Treg signaling transduction with the tumor, EAE and IBD model, which will provide strategies for not only basic research but also clinical study. 3) As malignant cells, which can be distorted by gene mutation, tumor can escape immune surveillance, which leads to tumor tolerance and ultimately destroys human health. In our group, we focus on the role of these proteins in immune escape, which could provide new theoretical basis and drug targets for the prevention, diagnosis and treatment of tumors.

OCM Member
Professor
The University of Oxford , United Kingdom
Biography :

Prof. Tomas Hanke is a Professor of Immunology at the University of Oxford and a Distinguished Immunology Professor at Kumamoto University in Japan. His research aims to develop a universal HIV-1 vaccine, which targets most global virus variants including escape mutants. He explores novel vaccine modalities and optimizes their immunogenicity in heterelogous prime-boost regimens in mice and macaques. He co-ordinates a clinical program assessing candidate HIV vaccines in humans in UK, Europe and Africa. You can read more information about his work: The proposed work under Advancing HIV Therapeutic Vaccine Science (U01) will work cooperatively with academic institutions, industry and NIAID to conduct a coordinated research program to test a first-in-human trial of candidate T-cell vaccines tHIVconsvX. I am delighted to participate as an investigator on this proposal. My research aims to develop a universal HIV-1 vaccine that targets most global virus variants including escape mutants. This is achieved by focusing the vaccine-elicited responses on the most conserved regions of the HIV-1 proteins, which are common to most global variants and typically decrease the virus replicative fitness if mutated. Global coverage is enhanced by a bivalent mosaic design. Overall, I strive to maintain a balance between basic and translational research. I oversee a busy pre-clinical programme encompassing HIV-1 epitope discovery and dynamics using mass spectrometry and T-cell assays, studies on immunodominance, depth (number of variants) of epitope recognition, and the importance of perfect vaccine-virus epitope matching for effective effector functions. I also explore novel vaccine modalities and optimize their immunogenicity in heterelogous prime-boost regimens in mice and macaques. I co-ordinate a clinical programme assessing candidate HIV-1 vaccines in humans in UK, Europe and Africa. I look forward to working with PI Dr. Goonetilleke, U01 colleagues and NIAID to conduct the proposed clinical trial in parallel with my other clinical program, advancing this vaccine strategy to characterize the elicited responses and their protective potential, with the ultimate goal to discover HIV prevention and cure.

Research Interest :

Professor Perera’s primary research program focuses on monitoring in primary care, meta-analysis methods, methodology for studying infectious diseases in children, and assessing complex interventions. In the last five years, his research focus has turned to managing chronic conditions. He is currently PI on an NIHR (UK) funded Programme grant on Monitoring Long term conditions in Primary Care, focusing on improving the evidence for the management of Chronic Kidney Disease and Chronic Heart Failure. He is the author of more than 150 publications focusing on monitoring in primary care, meta-analysis methods, methodology for studying infectious diseases in children, and assessing complex interventions.

OCM Member
Professor
University of Tromsø , Norway
Biography :

Natasa Skalko-Basnet currently works at the Department of Pharmacy (IFA), University of Tromsø. Natasa does research in Dermatology, Gynaecology and Pharmacy. Their most recent publication is 'Lipid-Based Nanopharmaceuticals in Antimicrobial Therapy.

Research Interest :

Liposomes as novel drug delivery system in topical application, Biohydrogels, Topical formulations containing natural origin substances.

OCM Member
Research Director
The University of Texas , USA
Biography :

Dr. Mandy Hill completed her doctoral studies in public health (Disease Control) at the University of TX Health, School of Public Health and her master studies in epidemiology at Tulane School of Public Health & Tropical Medicine. She directs public health research in the department. Dr. Mandy Hill has acquired a wealth of academic experience in the design, development, and implementation of behavioral research within a clinical setting. Trained as a clinical researcher, Dr. Hill has a documented history of advancing a prevention-based public health agenda within a clinical environment. Her academic portfolio to date has been based on creating a niche of merging public health and emergency medicine. She has published 22 peer reviewed manuscripts, 10 of which she first authored, in diverse areas addressing health disparities among disadvantaged minority populations, coupled with 25 abstracts, 20 presentations and extramural funding support from the Center for Disease Control and Prevention and the National Institutes of Health through the American Psychological Association and Centers for AIDS Research, as well as industry sponsored research. These tangible outcomes attest to her scientific contributions to date. Her primary research focus is HIV/AIDS, STIs, and STDs. In summary, here expertise includes the design, implementation, and analysis of pilot and exploratory studies, randomized clinical trial development and implementation, and integrating public health-based prevention research into routine clinical visits in the emergency department.

Research Interest :

Professor Perera’s primary research program focuses on monitoring in primary care, meta-analysis methods, methodology for studying infectious diseases in children, and assessing complex interventions. In the last five years, his research focus has turned to managing chronic conditions. He is currently PI on an NIHR (UK) funded Programme grant on Monitoring Long term conditions in Primary Care, focusing on improving the evidence for the management of Chronic Kidney Disease and Chronic Heart Failure. He is the author of more than 150 publications focusing on monitoring in primary care, meta-analysis methods, methodology for studying infectious diseases in children, and assessing complex interventions.

Mail us at

Enquiry
stdaids@alliedevents.org
General Queries
stdaids@alliedevents.org
Sponsors/Exhibitors
stdaids@alliedevents.org
More details about sponsorship:sponsors@alliedacademies.com

Terms and Conditions

Responsibility

The organizers holds no responsibilities or liabilities of the personal articles of attendees at the venue against any kind of theft, lost, damage, due to any reason whatsoever. Delegates are entirely responsible for the safety of their own belongings.

Insurance

No insurance, of any kind, is included along with the registration in any of the events of the organization.

Transportation

Please note that transportation and parking is the responsibility of the registrant, Allied Academies will not be liable for any actions howsoever related to transportation and parking.

 

Press/Media

Press permission must be obtained from Allied Academies Conference Organizing Committee prior to the event. The press will not quote speakers or delegates unless they have obtained their approval in writing. The Allied Academies is an objective third-party non-profit organization and this conference is not associated with any commercial meeting company.

 

Requesting an Invitation Letter

For security purposes, letter of invitation will be sent only to those individuals who had registered for the conference after payment of complete registration fee. Once registration is complete, please contact infectiousdiseases@alliedconferences.org to request for a personalized letter of invitation, if not received until one month before the scheduled date of event.

All the bank charges applicable during refund will be deducted from the account of participant.

 

Cancellation Policy

All cancellations or modifications of registration must be made in writing to finance@alliedacademies.com

 

Postponement of event

If, due to any reason, Allied academies postpone an event and the participant is unable or unwilling to attend the conference on rescheduled dates, he/she is eligible for a credit of 100% of the registration fee paid. This credit shall only be used for another event organized by Allied academies within period of one year from the date of rescheduling.

 

Transfer of registration

All registrations, after payment of complete registration fee, are transferable to other persons from the same organization, if in case the person is unable to attend the event. Request for transfer of registration must be made by the registered person in writing to contact@alliedacademies.com . Details must include the full name of replaced new registrant, their title, contact phone number and email address. All other registration details will be assigned to the new person unless otherwise specified.

Registration can be transferred to one conference to another conference of Allied academies if the person is unable to attend one of conferences.

However, Registration cannot be transferred if intimated within 14 days of respective conference.

The transferred registrations will not be eligible for Refund.

This cancellation policy was last updated on April 04, 2015.

 

Visa Information

Keeping in view of increased security measures, we would like to request all the participants to apply for Visa as soon as possible.

Allied academies will not directly contact embassies and consulates on behalf of visa applicants. All delegates or invitees should apply for Business Visa only.

Important note for failed visa applications: Visa issues are not covered under the cancellation policy of Allied academies, including the inability to obtain a visa.

 

Refund Policy:

If the registrant is unable to attend, and is not in a position to transfer his/her participation to another person or event, then the following refund policies apply:

Keeping in view of advance payments towards Venue, Printing, Shipping, Hotels and other overhead charges, following Refund Policy Orders are available:

  • Before 60 days of the conference: Eligible for Full Refund after deduction of $100 towards service Fee.
  • Within 60-30 days of Conference: Eligible for 50% of payment Refund
  • Within 30 days of Conference: Not eligible for Refund
  • E-Poster Payments will not be refunded.

 

Accommodation Cancellation Policy:

Accommodation Service Providers (Hotels) have their own cancellation policies which are applicable when cancellations are made less than 30 days prior to arrival. If in case the registrant wishes to cancel or amend the accommodation, he/ she is expected to inform the organizing authorities on a prior basis. Allied academies will advise the registrant to ensure complete awareness about the cancellation policy of your accommodation provider, prior to cancellation or modification of their booking.

Authorization Policy

Copyright © 2018-2019 Allied Academies, All Rights Reserved.